You searched for "otological"

1013 results found

ENT/AUDIOLOGY in this issue March/April 2020

Emma Stapleton, MBChB, FRCS (ORL-HNS), Consultant Otolaryngologist, Cochlear Implant and Skull Base Surgeon, Manchester Royal Infirmary, UK. E: emmastapleton@doctors.org.uk Twitter: @otolaryngolofox Martin O’ Driscoll, Consultant Clinical Scientist; Head of Audiology and Hearing Implants, Audiology (Hearing and Balance) Centre, Manchester Royal...

ENT in this issue... Paediatric Otorhinolaryngology (NovDec18)

But for the clumsiness of increasing the number of letters in the acronym, ‘ENT’ would have grown to include recognition of the subspecialties of skull base surgery, facial plastic surgery and paediatric ENT surgery, of which management of ENT problems in children has seen perhaps the greatest development.

Audiology in this issue...Hyperacusis (Jan/Feb19)

Audiologists, otologists, and auditory neuroscientists are accustomed to dealing with problems of hearing loss but, until recently, little attention has been given to the experience of hearing sound too intensely. This experience is variously given the names hyperacusis, and reduced or decreased sound tolerance, and the affected individual finds everyday sound intensely and excruciatingly loud, rendering workplaces, shops, and social spaces intolerable.

3rd ENT Masterclass® World Congress

The 3rd ENT Masterclass World Congress at the Palace of Parliament was a perfect setting to celebrate the 20th Anniversary of ENT Masterclass. Two days of academic excellence saw over 250 delegates and faculty from all across Europe and beyond.

Thyroid cancer – the last decade

Professor Ashok Shaha describes the evolution in the treatment of thyroid cancer that he has witnessed over the last decade and the invaluable progress made by himself and others, from their contributions to staging systems and guidelines. Nuances and paradigm...

Coblation for laryngeal granulomas

Laryngeal granulomas remain notorious for their tendency to recur after surgical removal. Although high rates of complete remission have been reported with use of the potassium-titanyl-phosphate (KTP) laser, this equipment is expensive and not available in all units performing ENT...

Retrospective review of paediatric salivary gland tumours

As is the case with adults, primary tumours of the salivary glands in children comprise a heterogeneous collection of different histological types. This paper presents a retrospective review of primary salivary gland tumours in children treated over the course of...

Suspect the unsuspecting in thyroid cancer

This article reminds readers of how often invasive thyroid disease can appear, as the symptomatology is minimal. Noticeable airway symptoms appear after 50% of the airway is involved and surgeons can often fall in the unsuspecting trap of discovering locally...

The role of imaging in differentiating rare temporal bone neoplasms

This paper provides a useful tool to assist in determining the diagnosis of benign neoplasms of the temporal bone using readily available imaging modalities. Specifically, this group have looked at chondrosarcoma, an expansile hypermetabolic mass lesion usually found in the...

Salivary gland blues…

Intravenous methylene blue is a well-described method to assist in intraoperative localisation of parathyroid glands. The technique does come with challenges as anybody will know who has had to run adjacent to a theatre-bound trolley to ensure that the infusion...

Management of the neck in maxillary sinus carcinomas

Primary malignant tumours of the sinonasal tract account for less than 10% of head and neck cancers, of which the maxilla is the second most common subsite and squamous cell carcinoma (SCC) is the most prevalent histological type. Maxillary SCCs...

Adjuvant radiotherapy for T4N0 laryngeal cancers treated with laryngectomy

A total laryngectomy remains the gold standard for the initial treatment of advanced (T4) squamous cell carcinomas of the larynx without evidence of distant disease. Adjuvant radiotherapy (RT) is also recommended for such cancers. In the absence of other adverse...